samedan logo
 
 
spacer
home > pmps
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

 
Pharmaceutical Manufacturing and Packing Sourcer (PMPS) is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

Published quarterly, the journal functions as a platform of communication and information-sharing for executive and strategic decision makers within the industry, identifying new trends and marketing opportunities, as well as highlighting the latest innovations in this dynamic environment. PMPS is specifically designed to interest those in the pharma, biotech, nutritional, and medical device industries who are actively seeking to source services for improved efficiency in what is an increasingly competitive market.

For further information please contact:

Advertising
Simon Caplan

Editorial
James Spargo

We're also on Twitter! Follow us @PMPSmag   

 


Click here to view the digital version of PMPS

   

 












 

Click here to view the digital version of the FlyPharma Supplement 2022

   

 


Click here to view the digital version of Parenteral Technology Supplement 2022

   

 

pmps
 
 

spacer


Published quarterly in
February, May,
August, and November



 

 
News and Press Releases

Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery

London, UK, 22 September 2022 / Sciad Newswire / Connect in Pharma the new annual event from Easyfairs had its debut launch on 14 & 15 September in Geneva. Key players from companies in the pharmaceutical industry, including Bayer, Merck, Pfizer, Roche, Johnson & Johnson and GSK, among other, came together at Palexpo Convention Centre during the two-day event to hear about the latest innovations and developments in pharmaceutical manufacturing, drug delivery and contract manufacturing.
More info >>

 
White Papers

The Role of the CRO in Effective Risk-Based Monitoring

Medpace

The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement